NLRP3 and COVID-19: Proinflammatory cytokines and acute-phase reactants such as IL-1β and IL-18 caused by COVID-19 around NLRP3 activation may directly or indirectly cause inflammation and pancreatic β cell damage, resulting in severe insulin resistance and hyperglycemia.